Skip to content

Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates

By API User

REYKJAVIK, Iceland, Feb. 02, 2026 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it has entered into supply and commercialization agreements with Sandoz covering multiple biosimilar candidates in Canada, and in Australia and New Zealand. “These agreements with … Continued

Galderma Announces U.S. FDA Acceptance of RelabotulinumtoxinA Biologics License Application Resubmission

By API User

The United States (U.S.) Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) resubmission for RelabotulinumtoxinA for the temporary improvement of moderate-to-severe glabellar lines (frown lines) and lateral canthal lines (crow’s feet) in adults RelabotulinumtoxinA is designed to optimize molecule integrity to deliver fast onset of action as early as Day 1 … Continued

Hair cortisol may help us better understand stress and other conditions for people with autism

By API User

Hair cortisol may help us better understand the impact of stress on autistic children, new research has found. Autistic children may be non-verbal or not have the words or other typical communication strategies to clearly explain their feelings. Researchers from Neuroscience Research Australia (NeuRA) and UNSW Sydney have found hair cortisol levels may complement behavioural … Continued

The question everyone with breast cancer should ask on World Cancer Day

By API User

Key Facts: Breast cancer affects 2.3 million people globally each year, with 670,000 deaths worldwide and over 20,000 diagnoses in Australia annually Clinical trials are essential for improving breast cancer treatments, whether testing new therapies or optimising existing ones Breast Cancer Trials operates across Australia, New Zealand and internationally as a non-profit research organisation conducting … Continued

Meet the Melbourne barber shaving the world from blood cancer

By API User

World’s Greatest Shave Hair Ambassador Frank Ciccone: available for interview on request. Contact the Leukaemia Foundation media team at [email protected]. Images: view highlights from Frank’s time as Hair Ambassador. The Leukaemia Foundation’s iconic World’s Greatest Shave campaign returns in 2026, encouraging participants around the country to shave, cut or colour their hair in solidarity to raise critical funds and awareness for the 170,000i Australians facing blood cancer.  … Continued

Letter to the Editor

By API User

Blood cancer… the single biggest tragedy impacting Aussie kids and forcing them out of classrooms  As Australian children return to school, hundreds will not. Their desks sit empty as they fight blood cancer – the single biggest disease threatening the lives of school-aged children in Australia today.  This year alone, around 350 children will be diagnosed … Continued

Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis

By API User

Kyowa Kirin affirms commitment to developing rocatinlimab as a life-changing differentiated asset with significant market potential. Rocatinlimab’s novel approach as an investigational T-cell rebalancing therapy directly targeting the OX40 receptor expressed on pathogenic T-cells shows potential to deliver long-term disease control in patients with moderate-to-severe atopic dermatitis (msAD). Regulatory submission is planned in the first … Continued